Skip to main content
. Author manuscript; available in PMC: 2018 Jan 9.
Published in final edited form as: J Control Release. 2016 Jun 24;237:177–184. doi: 10.1016/j.jconrel.2016.06.032

Fig. 3.

Fig. 3

In vivo fluorescence images of U-87 MG tumor-bearing mice before and after intravenous injection of Cy5.5-iRGDC-BK01 and Cy5.5-iRGDC (50 μM). Blue and red circles indicate the tumor and the normal thigh regions nearby the tumor, respectively. The scales of the fluorescence intensity were adjusted to make maximum-to-minimum ratios of average tumor intensity the same.